Understanding the impact of COVID-19 on endothelial markers of coagulation and more broadly, on plasma thrombin and plasmin generation, at early disease presentation may offer better insights into anticoagulation needs and monitoring as well as assessing early disease severity. Here, PLG is linked to COVID-19.